Patents by Inventor Robert J. Collier, Jr.

Robert J. Collier, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of beta-adrenoceptor antagonists for the manufacture of a medicament of the treatment of disorders of the outer retina
    Patent number: 8710102
    Abstract: Compositions and methods for treating disorders of the outer retina with ?-adrenoceptor antagonists are disclosed.
    Type: Grant
    Filed: June 9, 2010
    Date of Patent: April 29, 2014
    Assignee: Novartis AG
    Inventors: Robert J. Collier, Jr., Michael A. Kapin, Louis DeSantis, Jr.
  • Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen
    Patent number: 8158609
    Abstract: The present invention is directed to the treatment of disorders involving the accumulation of drusen, such as dry age-related macular degeneration and geographic atrophy via administration of therapeutically effective amounts of at least one monomeric or polymeric cyclodextrin.
    Type: Grant
    Filed: November 2, 2007
    Date of Patent: April 17, 2012
    Assignee: Novartis AG
    Inventors: David Allen Marsh, Robert J. Collier, Jr., Michael A. Kapin, Youqin Tian, Eliot Mark Slovin
  • Superoxide dismutase mimics for the treatment of ocular disorders and diseases
    Patent number: 8067405
    Abstract: The use of SOD mimics, particularly Mn(III) salen SOD mimics, for the treatment of AMD, DR, and retinal edema is disclosed.
    Type: Grant
    Filed: March 24, 2010
    Date of Patent: November 29, 2011
    Assignee: Novartis AG
    Inventors: Peter G. Klimko, Robert J. Collier, Jr., Mark R. Hellberg
  • Superoxide dismutase mimics for the treatment of ocular disorders and diseases
    Patent number: 8003635
    Abstract: The use of SOD mimics particularly pentaazacycle Mn(II) complex SOD mimics, for the treatment of AMD, DR, and retinal edema is disclosed.
    Type: Grant
    Filed: April 23, 2010
    Date of Patent: August 23, 2011
    Assignee: Novartis AG
    Inventors: Peter G. Klimko, Robert J. Collier, Jr., Mark R. Hellberg
  • Use of Monoamine Oxidase Inhibitors to Treat Outer Retina Disorders
    Publication number: 20110160308
    Abstract: Compositions and methods for treating disorders of the outer retina with compounds that inhibit monoamine oxidase are disclosed.
    Type: Application
    Filed: July 27, 2007
    Publication date: June 30, 2011
    Applicant: ALCON RESEARCH, LTD.
    Inventors: Robert J. Collier, JR., Michael A. Kapin, John M. Yanni
  • Use of Beta-Adrenoceptor Antagonists for the Manufacture of a Medicament for the Treatment of Disorders of the Outer Retina
    Publication number: 20100249134
    Abstract: Compositions and methods for treating disorders of the outer retina with ?-adrenoceptor antagonists are disclosed.
    Type: Application
    Filed: June 9, 2010
    Publication date: September 30, 2010
    Applicant: ALCON, INC.
    Inventors: Robert J. Collier, Jr., Louis DeSantis, JR., Michael A. Kapin
  • SUPEROXIDE DISMUTASE MIMICS FOR THE TREATMENT OF OCULAR DISORDERS AND DISEASES
    Publication number: 20100204194
    Abstract: The use of SOD mimics particularly pentaazacycle Mn(II) complex SOD mimics, for the treatment of AMD, DR, and retinal edema is disclosed.
    Type: Application
    Filed: April 23, 2010
    Publication date: August 12, 2010
    Applicant: ALCON, INC.
    Inventors: Peter G. Klimko, Robert J. Collier, JR., Mark R. Hellberg
  • Compounds with 5-HTactivity useful for treating disorders of the outer retina
    Patent number: 7763619
    Abstract: Compositions and methods for treating disorders of the outer retina with compounds with 5-HT1A agonist activity are disclosed.
    Type: Grant
    Filed: July 22, 2005
    Date of Patent: July 27, 2010
    Assignee: Alcon, Inc.
    Inventors: Robert J. Collier, Jr., Michael A. Kapin, Mark R. Hellberg, Thomas R. Dean
  • Superoxide dismutase mimics for the treatment of ocular disorders and diseases
    Patent number: 7759333
    Abstract: The use of SOD mimics particularly pentaazacycle Mn(II) complex SOD mimics, for the treatment of AMD, DR, and retinal edema is disclosed.
    Type: Grant
    Filed: December 6, 2002
    Date of Patent: July 20, 2010
    Assignee: Alcon, Inc.
    Inventors: Peter G. Klimko, Robert J. Collier, Jr., Mark R. Hellberg
  • SUPEROXIDE DISMUTASE MIMICS FOR THE TREATMENT OF OCULAR DISORDERS AND DISEASES
    Publication number: 20100179117
    Abstract: The use of SOD mimics, particularly Mn(III) salen SOD mimics, for the treatment of AMD, DR, and retinal edema is disclosed.
    Type: Application
    Filed: March 24, 2010
    Publication date: July 15, 2010
    Applicant: ALCON, INC.
    Inventors: Peter G. Klimko, Robert J. Collier, JR., Mark R. Hellberg
  • Superoxide dismutase mimics for the treatment of ocular disorders and diseases
    Patent number: 7754706
    Abstract: The use of SOD mimics, particularly Mn(III) salen SOD mimics, for the treatment of AMD, DR, and retinal edema is disclosed.
    Type: Grant
    Filed: December 5, 2003
    Date of Patent: July 13, 2010
    Assignee: Alcon, Inc.
    Inventors: Peter G. Klimko, Robert J. Collier, Jr., Mark R. Hellberg
  • COMPOUNDS WITH 5-HT1A ACTIVITY USEFUL FOR TREATING DISORDERS OF THE OUTER RETINA
    Publication number: 20100168121
    Abstract: Compositions and methods for treating disorders of the outer retina with compounds with 5-HT1A agonist activity are disclosed.
    Type: Application
    Filed: March 8, 2010
    Publication date: July 1, 2010
    Applicant: ALCON, INC.
    Inventors: Robert J. Collier, JR., Michael A. Kapin, Mark R. Hellberg, Thomas R. Dean
  • Use of ?-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina
    Patent number: 7081482
    Abstract: The invention is directed to the use of ?-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina.
    Type: Grant
    Filed: November 29, 2000
    Date of Patent: July 25, 2006
    Assignee: Alcon, Inc.
    Inventors: Robert J. Collier, Jr., Louis Desantis, Jr., Michael A. Kapin
  • Compounds with 5-ht activity useful for controlling visual field loss
    Publication number: 20030119846
    Abstract: Compounds with 5-HT1A agonist activity which are useful for controlling the visual field loss associated with glaucoma are disclosed.
    Type: Application
    Filed: September 9, 2002
    Publication date: June 26, 2003
    Inventors: Robert J. Collier Jr, Mark R. Hellberg, Thomas R. Dean
  • Treatment of disorders of the outer retina
    Patent number: 6509355
    Abstract: This invention is directed to the use of glutamate antagonists to treat the disorders of outer retina.
    Type: Grant
    Filed: April 18, 2001
    Date of Patent: January 21, 2003
    Assignee: Alcon Laboratories, Inc.
    Inventors: Robert J. Collier, Jr., Mark R. Hellberg, Michael A. Kapin, George E. Barnes, Michael L. Chandler
  • Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina
    Publication number: 20020193373
    Abstract: The invention is directed to the use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina.
    Type: Application
    Filed: May 15, 2002
    Publication date: December 19, 2002
    Inventors: Robert J. Collier, Jr., Louis Desantis, Jr., Michael A. Kapin
  • Angiostatic compounds
    Patent number: 5719167
    Abstract: The present invention is directed to compositions containing angiostatic compounds and methods for their use in preventing pathological neovascularization.
    Type: Grant
    Filed: August 7, 1995
    Date of Patent: February 17, 1998
    Assignee: Alcon Laboratories, Inc.
    Inventors: Rupa Doshi, Jon Nixon, Robert J. Collier, Jr.
  • Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
    Patent number: 5691360
    Abstract: Compounds having both calcium antagonist and antioxidant activity are disclosed. The compounds are useful in preventing or alleviating damage to tissues at the cellular level. Methods of treatment which employ these properties of the compounds and corresponding pharmaceutical compositions are also disclosed.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 25, 1997
    Assignee: Alcon Laboratories, Inc.
    Inventors: Mark R. Hellberg, George Barnes, Robert J. Collier, Jr.
  • Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
    Patent number: 5646149
    Abstract: Compounds having both calcium antagonist and antioxidant activity are disclosed. The compounds are useful in preventing or alleviating damage to tissues at the cellular level. Methods of treatment which employ these properties of the compounds and corresponding pharmaceutical compositions are also disclosed.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 8, 1997
    Assignee: Alcon Laboratories, Inc.
    Inventors: Mark R. Hellberg, George Barnes, Robert J. Collier, Jr.
  • Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
    Patent number: 5424321
    Abstract: Compounds having both calcium antagonist and antioxidant activity are disclosed. The compounds are useful in preventing or alleviating damage to tissues at the cellular level. Methods of treatment which employ these properties of the compounds and corresponding pharmaceutical compositions are also disclosed.
    Type: Grant
    Filed: December 8, 1993
    Date of Patent: June 13, 1995
    Assignee: Alcon Laboratories, Inc.
    Inventors: Mark R. Hellberg, George Barnes, Robert J. Collier, Jr.